NO302366B1 - 4-merkaptoacetylamino-£2|benzazepinon(3)-derivater, og farmasöytisk preparat - Google Patents
4-merkaptoacetylamino-£2|benzazepinon(3)-derivater, og farmasöytisk preparatInfo
- Publication number
- NO302366B1 NO302366B1 NO944430A NO944430A NO302366B1 NO 302366 B1 NO302366 B1 NO 302366B1 NO 944430 A NO944430 A NO 944430A NO 944430 A NO944430 A NO 944430A NO 302366 B1 NO302366 B1 NO 302366B1
- Authority
- NO
- Norway
- Prior art keywords
- mercaptoacetylamino
- benzazepinone
- derivatives
- pharmaceutical preparation
- enkephalinase
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- GYXHHICIFZSKKZ-UHFFFAOYSA-N 2-sulfanylacetamide Chemical compound NC(=O)CS GYXHHICIFZSKKZ-UHFFFAOYSA-N 0.000 abstract 1
- 102000003729 Neprilysin Human genes 0.000 abstract 1
- 108090000028 Neprilysin Proteins 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Ophthalmology & Optometry (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/886,029 US5238932A (en) | 1992-05-20 | 1992-05-20 | Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| PCT/US1993/003150 WO1993023397A1 (en) | 1992-05-20 | 1993-04-06 | 4-mercaptoacetylamino-[2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO944430D0 NO944430D0 (no) | 1994-11-18 |
| NO944430L NO944430L (no) | 1995-01-17 |
| NO302366B1 true NO302366B1 (no) | 1998-02-23 |
Family
ID=25388225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO944430A NO302366B1 (no) | 1992-05-20 | 1994-11-18 | 4-merkaptoacetylamino-£2|benzazepinon(3)-derivater, og farmasöytisk preparat |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5238932A (forum.php) |
| EP (1) | EP0641343B1 (forum.php) |
| JP (1) | JP3295848B2 (forum.php) |
| KR (1) | KR100281608B1 (forum.php) |
| AT (1) | ATE243694T1 (forum.php) |
| AU (1) | AU669716B2 (forum.php) |
| CA (1) | CA2135751C (forum.php) |
| DE (1) | DE69333062T2 (forum.php) |
| DK (1) | DK0641343T3 (forum.php) |
| ES (1) | ES2201058T3 (forum.php) |
| FI (1) | FI108136B (forum.php) |
| HU (1) | HUT71107A (forum.php) |
| IL (1) | IL105727A (forum.php) |
| MX (1) | MX9302906A (forum.php) |
| NO (1) | NO302366B1 (forum.php) |
| NZ (1) | NZ252785A (forum.php) |
| PT (1) | PT641343E (forum.php) |
| TW (1) | TW269682B (forum.php) |
| WO (1) | WO1993023397A1 (forum.php) |
| ZA (1) | ZA933423B (forum.php) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5430145A (en) * | 1990-10-18 | 1995-07-04 | Merrell Dow Pharmaceuticals Inc. | Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| US5308841A (en) * | 1990-12-21 | 1994-05-03 | Merrell Dow Pharmaceuticals Inc. | Amino and nitro containing tricyclic compounds useful as inhibitors of ACE |
| US5457196A (en) * | 1991-09-27 | 1995-10-10 | Merrell Dow Pharmaceuticals Inc. | 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE |
| US5455242A (en) * | 1991-09-27 | 1995-10-03 | Merrell Dow Pharmaceuticals Inc. | Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace |
| ZA927211B (en) * | 1991-09-27 | 1993-03-24 | Merrell Dow Pharma | Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE. |
| DE69220744T2 (de) * | 1991-09-27 | 1997-11-13 | Merrell Pharma Inc | 2-Substituierte Indan-2-Mercaptoacetylamid-Verbindungen mit Enkephalinase und ACE-Hemmwirkung |
| DE69317764T2 (de) * | 1992-02-14 | 1998-07-30 | Merrell Pharmaceuticals Inc., Cincinnati, Ohio | Aminoacetylmercaptoacetylamid derivate mit enkephalinase- und ace-hemmwirkung |
| US5420271A (en) * | 1992-08-24 | 1995-05-30 | Merrell Dow Pharmaceuticals, Inc. | 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| US5635502A (en) * | 1992-10-30 | 1997-06-03 | Merrell Pharmaceuticals Inc. | Mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ACE |
| NZ267161A (en) * | 1993-06-11 | 1996-12-20 | Eisai Co Ltd | Dipeptidic benzazepine derivative with ace inhibiting activity |
| AU680512B2 (en) * | 1993-06-11 | 1997-07-31 | Eisai Co. Ltd. | Amino acid derivative |
| PT750631E (pt) * | 1994-02-14 | 2000-07-31 | Merrell Pharma Inc | Novos derivados de dissulfureto de mercapto-aacetilamido-1,3,4,5-tetra-hidro-benzo¬c)azepin-3-ona uteis como inibidores de encefalinase e ace |
| HUT76479A (en) * | 1994-02-14 | 1997-09-29 | Merrell Pharma Inc | Novel fused benzazepinone derivatives, process for preparation thereof and pharmaceutical composition containing them |
| US5530013A (en) * | 1994-02-14 | 1996-06-25 | American Home Products Corporation | Venlafaxine in the inducement of cognition enhancement |
| HUT74461A (en) * | 1994-02-14 | 1996-12-30 | Merrell Pharma Inc | Condenzed azepine-derivatives of mercaptoacetylamide disulfides useful as inhibitors of enkephalinase, pharmaceutical compositions containing the same and process for producing them |
| JP3608624B2 (ja) * | 1994-02-14 | 2005-01-12 | メレル ファーマスーティカルズ インコーポレーテッド | エンケファリナーゼ阻害剤として有用な新規なインダン−２−メルカプトアセチルアミドジスルフィド誘導体類 |
| US5484783A (en) * | 1994-03-24 | 1996-01-16 | Merrell Dow Pharmaceuticals Inc. | Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives |
| DE69531489T2 (de) * | 1994-03-24 | 2004-04-08 | Merrell Pharmaceuticals Inc., Cincinnati | Cholesterin senkende mercaptoacetylamiddisulfidderivate |
| ATE189392T1 (de) * | 1994-03-24 | 2000-02-15 | Merrell Pharma Inc | Hypocholesterolemische, antiatherosklerotische und hypotriglyceridemische verwendung von aminoacetylmercapto derivaten |
| US5641880A (en) * | 1994-12-21 | 1997-06-24 | Hoechst Marion Roussel, Inc. | Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
| WO1996019492A1 (en) * | 1994-12-21 | 1996-06-27 | Hoechst Marion Roussel, Inc. | Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
| US6953788B1 (en) | 1996-09-19 | 2005-10-11 | Aventis Pharmaceuticals Inc. | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| US6683075B1 (en) | 1996-12-23 | 2004-01-27 | Athena Neurosciences, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use |
| US6635632B1 (en) | 1996-12-23 | 2003-10-21 | Athena Neurosciences, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| IT1298268B1 (it) * | 1998-02-18 | 1999-12-20 | Zambon Spa | Procedimento per la preparazione dell'acido (s)-2-bromo-3-fenil- propionico |
| US6528505B1 (en) | 1998-06-22 | 2003-03-04 | Elan Pharmaceuticals, Inc. | Cyclic amino acid compounds pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| US6958330B1 (en) | 1998-06-22 | 2005-10-25 | Elan Pharmaceuticals, Inc. | Polycyclic α-amino-ε-caprolactams and related compounds |
| US6509331B1 (en) | 1998-06-22 | 2003-01-21 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| US6774125B2 (en) * | 1998-06-22 | 2004-08-10 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| US6569851B1 (en) * | 1998-06-22 | 2003-05-27 | Elan Pharmaceutials, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| US6552013B1 (en) | 1998-06-22 | 2003-04-22 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| CA2363847A1 (en) * | 1999-01-12 | 2000-07-20 | Kenneth Blum | Treatment of hypertension with compounds that inhibit the destruction of enkephalins or endorphins |
| WO2001068674A2 (en) * | 2000-03-13 | 2001-09-20 | Monsanto Technology Llc | Preparation of recombinant proteins containing repeating units |
| GB0119305D0 (en) | 2001-04-12 | 2001-10-03 | Aventis Pharma Gmbh | Mercaptoacetylamide derivatives,a process for their preparation and their use |
| US20050192265A1 (en) * | 2003-03-20 | 2005-09-01 | Thompson Richard C. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| CN116535304B (zh) * | 2023-03-31 | 2024-07-19 | 中国科学院成都生物研究所 | 毛兰素类似物及其合成方法和应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4415496A (en) * | 1981-03-23 | 1983-11-15 | Merck & Co., Inc. | Bicyclic lactams |
| ZA833214B (en) * | 1982-05-12 | 1983-12-28 | Hoffmann La Roche | Bicyclic compounds |
| GB2128984B (en) * | 1982-05-12 | 1985-05-22 | Hoffmann La Roche | Diaza-bicyclic compounds |
| US4584294A (en) * | 1984-11-07 | 1986-04-22 | Merck & Co., Inc. | Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents |
| JPH0678531B2 (ja) * | 1986-06-11 | 1994-10-05 | 株式会社日立製作所 | 石炭ガス化方法及び装置 |
| US4973585A (en) * | 1986-06-13 | 1990-11-27 | Merrell Dow Pharmaceuticals | Tricyclic lactams active as antihypertensive agents |
| ZA874106B (en) * | 1986-06-13 | 1987-12-08 | Merrell Dow Pharmaceuticals Inc. | Novel antihypertensive agent |
| CA1337654C (en) * | 1986-06-13 | 1995-11-28 | Gary A. Flynn | Fused tricyclic lactams as antihypertensive agents |
| US4824832A (en) * | 1987-12-30 | 1989-04-25 | Merrell Dow Pharmaceuticals Inc. | Sulfhydryl containing tricyclic lactams and their pharmacological methods of use |
| GB8926512D0 (en) * | 1989-11-23 | 1990-01-10 | Pfizer Ltd | Therapeutic agents |
| US5407960A (en) * | 1989-12-22 | 1995-04-18 | Schering Corporation | Mercaptocycloacyl aminoacid endopeptidase inhibitors |
| CA2053340C (en) * | 1990-10-18 | 2002-04-02 | Timothy P. Burkholder | Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
-
1992
- 1992-05-20 US US07/886,029 patent/US5238932A/en not_active Expired - Fee Related
-
1993
- 1993-04-06 ES ES93912116T patent/ES2201058T3/es not_active Expired - Lifetime
- 1993-04-06 AT AT93912116T patent/ATE243694T1/de not_active IP Right Cessation
- 1993-04-06 EP EP93912116A patent/EP0641343B1/en not_active Expired - Lifetime
- 1993-04-06 AU AU42779/93A patent/AU669716B2/en not_active Ceased
- 1993-04-06 DK DK93912116T patent/DK0641343T3/da active
- 1993-04-06 NZ NZ252785A patent/NZ252785A/en not_active IP Right Cessation
- 1993-04-06 PT PT93912116T patent/PT641343E/pt unknown
- 1993-04-06 JP JP52021093A patent/JP3295848B2/ja not_active Expired - Fee Related
- 1993-04-06 WO PCT/US1993/003150 patent/WO1993023397A1/en active IP Right Grant
- 1993-04-06 KR KR1019940704127A patent/KR100281608B1/ko not_active Expired - Fee Related
- 1993-04-06 DE DE69333062T patent/DE69333062T2/de not_active Expired - Fee Related
- 1993-04-06 HU HU9403323A patent/HUT71107A/hu unknown
- 1993-04-06 CA CA002135751A patent/CA2135751C/en not_active Expired - Fee Related
- 1993-05-17 ZA ZA933423A patent/ZA933423B/xx unknown
- 1993-05-18 TW TW082103913A patent/TW269682B/zh active
- 1993-05-18 IL IL10572793A patent/IL105727A/xx not_active IP Right Cessation
- 1993-05-19 MX MX9302906A patent/MX9302906A/es not_active IP Right Cessation
-
1994
- 1994-11-18 NO NO944430A patent/NO302366B1/no unknown
- 1994-11-18 FI FI945434A patent/FI108136B/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HUT71107A (en) | 1995-11-28 |
| NO944430D0 (no) | 1994-11-18 |
| NO944430L (no) | 1995-01-17 |
| US5238932A (en) | 1993-08-24 |
| JP3295848B2 (ja) | 2002-06-24 |
| DE69333062D1 (de) | 2003-07-31 |
| IL105727A (en) | 2000-11-21 |
| FI108136B (fi) | 2001-11-30 |
| JPH07506827A (ja) | 1995-07-27 |
| FI945434A0 (fi) | 1994-11-18 |
| MX9302906A (es) | 1993-11-01 |
| CA2135751A1 (en) | 1993-11-25 |
| KR950701632A (ko) | 1995-04-28 |
| EP0641343B1 (en) | 2003-06-25 |
| PT641343E (pt) | 2003-10-31 |
| DK0641343T3 (da) | 2003-10-13 |
| EP0641343A1 (en) | 1995-03-08 |
| CA2135751C (en) | 1999-09-21 |
| DE69333062T2 (de) | 2004-05-06 |
| FI945434L (fi) | 1994-11-18 |
| TW269682B (forum.php) | 1996-02-01 |
| AU4277993A (en) | 1993-12-13 |
| AU669716B2 (en) | 1996-06-20 |
| ATE243694T1 (de) | 2003-07-15 |
| KR100281608B1 (ko) | 2001-02-15 |
| WO1993023397A1 (en) | 1993-11-25 |
| ZA933423B (en) | 1993-12-08 |
| IL105727A0 (en) | 1993-09-22 |
| HU9403323D0 (en) | 1995-02-28 |
| ES2201058T3 (es) | 2004-03-16 |
| NZ252785A (en) | 1995-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO302366B1 (no) | 4-merkaptoacetylamino-£2|benzazepinon(3)-derivater, og farmasöytisk preparat | |
| NZ240230A (en) | Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof | |
| NO942994D0 (no) | Aminoacetylmercaptoacetylamidderivater som er anvendbare som inhibitorer av enkefalinase og ACE | |
| FI20031381A7 (fi) | Menetelmä antihistamiinisten 4-difenyylimetyylipiperidiinijohdannaisten valmistamiseksi | |
| MX9206851A (es) | Sales organicas de n,n'-diacetil cistina, proceso para su preparacion y composicion farmaceutica que las contiene. | |
| FI963169L (fi) | Enkefalinaasin ja ACE:n inhibittoreina käyttökelpoisia uusia merkaptoasetyyliamido-1,3,4,5-tetrahydrobents/c/-atsepin-3-onidisulfidijohdannaisia | |
| FI953899A7 (fi) | Substituoituja atsolonijohdannaisia Helicobacterin aiheuttamien sairauksien hoitamiseksi | |
| ITTO930346A0 (it) | Procedimento per la preparazione di derivati taurocolanici. | |
| IS3814A (is) | Aðferð til framleiðslu á lyfjablöndum | |
| IT8720260A0 (it) | Derivati di 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro applicazione come medicamenti. | |
| BG100248A (bg) | Инхибитори на скваленсинтетаза | |
| IT1233446B (it) | Derivati della 3 piperidinocarbaldeide ossima, loro procedimento di preparazione e loro applicazione come farmaci | |
| PT89742A (pt) | Processo de preparacao de 24r-cimnol e de suas composicoes farmaceuticas | |
| ES2061775T3 (es) | Derivados de estrobirulina, su obtencion y empleo. | |
| FI953617A7 (fi) | Menetelmä substituoitujen 4-hydroksikumariinien valmistamiseksi | |
| HUT65256A (en) | Process for producing 2-mercapto methylene-tetrahydronaphtalene-2-carboxamide derivatives and pharmaceutical preparations containing them | |
| ITTO930667A0 (it) | Procedimento per la preparazione di ethalfluralin | |
| DK0703916T3 (da) | 14-Substituerede marcfortiner og derivater, der kan anvendes som antispirant-midler | |
| IT8821369A0 (it) | Composizione farmaceutica utile per il trattamento di malattie cardiovascolari. | |
| NO883987L (no) | Fremgangsmaate for fremstilling av n-(substituert aklyliden) kondensert bicykloalkyliden og anvendelse derav som medikamenter. | |
| FI955556L (fi) | Symmetristen tai epäsymmetristen disubstituoitujen N-syaaniditioiminokarbonaattien valmistus | |
| ITMI931174A0 (it) | Composizioni farmaceutiche per la cura della talassemia | |
| ITMI931684A0 (it) | Procedimento per la preparazione di derivati del 5,4- diidrocarbostirile | |
| FI933004A7 (fi) | Menetelmä N-alkyyli-3,4-dialkyylioksianiliinien ja niiden johdannaisten valmistamiseksi | |
| NO924276L (no) | Fremgangsmaate for fremstilling av laktonet av 1r,cis-2,2-dimethyl-3-formyl-cyclopropan-1-karboksylsyre og mellomprodukter for anvendelse ved fremgangsmaaten |